Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. Pishvaian

26 Jun 2024

Abstract excerpt

Pancreatic cancer, with its alarming rising incidence, is predicted to become the second deadliest type of solid tumor by 2040, highlighting the urgent need for improved diagnostic and treatment strategies. Despite medical advancements, the five-year survival rate for pancreatic cancer remains about 14%, dropping further when metastasized. This review explores the promise of biomarkers for early detection,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39001391
DOI: 10.3390/cancers16132329

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. PishvaianPMID 39001391Read ↗

Pancreatic cancer subtyping - the keystone of precision treatmentSemantic proximity Read ↗

Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.Semantic proximity Read ↗

Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges.Semantic proximity Read ↗

Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future PerspectivesSemantic proximity Read ↗

Genetic and molecular alterations in pancreatic cancer: Implications for personalized medicineSemantic proximity Read ↗

Pancreatic Cancer: Genetics, Screening, Prevention, and Treatment.Semantic proximity Read ↗

The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectivesSemantic proximity Read ↗

Pancreatic biomarkers: could they be the answer?Semantic proximity Read ↗

Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside TranslationSemantic proximity Read ↗

Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.Semantic proximity Read ↗

UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better.Semantic proximity Read ↗

Advances in the Genetics and Biology of Pancreatic Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.